Friday, 18 Aug 2017

You are here

H1N1 Vaccination Triggers TLR Activation and Autoantibody Production in DMARD-naïve pSS

Increased morbidity and mortality from infectious causes in patients with autoimmune disorders has led to the overall consensus that vaccination of such patients is important and should be widely promoted in clinical practice. However, the autoimmune-biased immune system of the patient with rheumatic disease and use of immunosuppressive drugs tend to affect response to vaccination.

Published studies have shown reduced immunization responses with decreased protective antibody titers in such patients. As H1N1-related mortality amongst a younger population increased, it has become a common practice to provide protective immunization to all.

This Swedish study was designed to assess immune response to the vaccine of DMARD naïve primary Sjogren’s (pSS) patients. Primary SS patient with +SSA and SSB antibodies and matched healthy controls were vaccinated twice with adjuvanted inactivated H1N1 vaccine. Blood samples were collected and clinical parameters assess prior to, at week 1 and week 3 after each vaccination.

Researchers observed markedly higher levels of H1N1 influenza-specific IgG antibodies in patients, mainly of the IgG1 subclass, compared with controls. Furthermore, H1N1 antibodies developed by the patients had higher avidity than those of controls. Similar response was observed with influenza A and B strains.

Further investigation of antibodies to non-influenza pathogen Epstein-Barr virus (EBV) showed that antibody titers to EBV increased in patients following vaccination, but not incontrols. In terms of clinical response, increased frequency of fever, fatigue, myalgia and arthralgia were observed during the vaccination period.

H1N1 vaccination in pSS induced higher specific antibody responses in untreated autoimmune patients with pSS, and drove polyclonal B cell activation, including that of autoreactive cells, leading to an increase in autoantibody titers. High basal serum levels of the pro-inflammatory cytokines IFN-α, BAFF and TNF-α were observed in untreated patients with pSS during vaccination period. Researchers speculated that such response is possibly due to endosomal TLR stimulation (TLR7 and TLR9 in particular).

That would also explain the fact that such stimulatory effect was abolished in patient treated with hydroxychloroquine (HCQ). It is known that HCQ acts by inhibiting endosomal TLR signaling and subsequent B cell class switch and cytokine production.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Rheumatologists' Comments

So does the study with treatment naive patients and influenza vaccine mean we should or should not vaccinate this group of patients?

More Like This

Duration of Azathioprine Maintenance in AAV Does Not Alter Relapse Rates

A European multicentre study examined whether the duration of azathioprine (AZA) maintenance therapy in ANCA-associated vasculitis patients would influence the relapse rate during long-term follow-up.

Mycophenolate and Steroids in Neuropsychiatric Lupus

Beyond diagnosis, management of neuropsychiatric lupus (NPSLE) can be challenging. Moreover, there are scant studies addressing optimal management. In this issue of Clinical Rheumatology, researchers show the efficacy of mycophenolate mofetil (MMF) and deflazacort in NPSLE.

Lupus Hospitalizations are Common

Patients with systemic lupus erythematosus (SLE) incur substantial morbidity and complications that may lead to hospitalizations and increased cost of lupus care. Researchers from the University Health Network in Toronto have published a review of SLE hospitalizations showing thta while commone (for either infection or lupus activity), only 2.8% of hospitalizations resulted in death.

Increased Pulmonary Embolism Risk in Lupus Patients

Systemic lupus erythematosus (SLE) poses numerous vascular risks, many of which are thought to be autoantibody mediated.

A retrospective population-based analysis was done to determine the association of SLE and plumonary embolism (PE) using the National Hospital Discharge Survey data, a representative sample of hospital discharges throughout the United States.

Tubulointerstitial Damage in Lupus Predicts ESRD Progression

The presence of tubulointerstitial damage (TID) may provide a potential window for early intervention in lupus nephritis (LN) to ward off end-stage renal disease (ESRD), according to a data analysis.